Sonoma pharmaceuticals to present at upcoming spring virtual investor conferences

Woodstock, ga.--(business wire)--sonoma pharmaceuticals, inc. (nasdaq: snoa), a global healthcare leader developing and producing stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that ceo amy trombly and cfo jerry dvonch will present at the following upcoming virtual conferences.   event   h.c. wainwright global life sciences conference date   march 9-10, 2021
SNOA Ratings Summary
SNOA Quant Ranking